{
  "catalogId": "9e1aa691-43da-4293-8bd2-88b1aab21ca8",
  "name": "ANASTROZOLE TEVA ®",
  "status": "",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "141 32 31760 01",
  "treatmentDescriptions": "Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen.  Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.",
  "termsOfIssue": "Prescription required",
  "form": "tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ANASTROZOLE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L02BG03",
      "name": "ANASTROZOLE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "ANASTROZOLE INOVAMED 1MG 30TAB",
      "manufacturer": {
        "name": "אינובמד",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVDC/ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "6697",
        "yarpa": "84771",
        "pharmasoft": "9345"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 121.5123,
        "retailMargin": 25.0,
        "maxRetailPrice": 151.890375,
        "maxPriceWithVAT": 179.2306425
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T00:19:13.459450"
  }
}